ftInvstr
SUPRIYA · Healthcare ₹845.9 +0.46% Mkt Cap ₹6816 Cr

SUPRIYA

Healthcare Biotechnology
₹845.9
+0.46% today · 30d -4.85%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for SUPRIYA. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹190 Cr
+30.79% YoY
NET PROFIT
₹24 Cr
-30.89% YoY
OPM
26.04%
-10.76pp YoY
EPS
₹2.99
PE 36.88
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-47.4%, h2=-46.0%, h3=-46.8% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SUPRIYA36.88
BIOCON154.516.88
ANTHEM91.3531.1
ONESOURCE5.79
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
71
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation FAIR 40
Growth STEADY 68
Profitability HIGH 90
Technicals WEAK 47
Risk LOW 90
Key Stats
TTM PE
36.88
P/B
6.11
52W HIGH
₹1085.0
OFF HIGH
-22.04%
DIV YIELD
0.12%
MKT CAP
₹6816 Cr
◉ Active Signals
MACDNeutral7.5163
RSI(14)Neutral54.26
Street Consensus
2 analysts
₹940.0
mean target
Low ₹850.0Now ₹845.9High ₹1030.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SUPRIYA and at what entry.

Sign up freeSign in